Monday, the United Arab Emirates announced that it will be offering the Chinese Sinopharm COVID-19 vaccine for children aged between three and 17, according to the country’s National Emergency Crisis and Disaster Management Authority (NCEMA).

This came after clinical trials and “extensive evaluations and is based on the emergency use authorization and local evaluations which are in line with the approved regulations,” the NCEMA tweeted.

In June, the UAE launched a clinical trial administering the Sinopharm vaccine to children aged between three and 17.

At the time, the Abu Dhabi Media office had announced that the trial will monitor the immune response of 900 children “in preparation to vaccinate children in the near future.” A number of members of Abu Dhabi’s ruling family participated in the trial.

In May, the UAE approved the Pfizer-BioNTech coronavirus vaccine for emergency use in children aged 12-15. Dubai started inoculating that age group in June.

Since the beginning of the coronavirus pandemic, the UAE has confirmed 683,914 cases and 1,956 deaths.